aon glp 1 study shows GLP-1s can save $200B annually | Carter Williams posted on the topic Aon Unveils First Workforce-Focused Analysis

PlushCare is an online clinic that connects you with licensed US doctors to prescribe FDA-approved GLP1 weight-loss medications like Ozempic, Wegovy, and Mounjaro

If validated, this approach could mark a major advance in personalized medicine, providing patients with therapies that target both metabolic dysfunction and autoimmune inflammation

Thus, the spectrum to consider is expansive, including Glu from GLP-1, Asp similar to Glu from GIP, Ala, and even Leu/Ile/Val (forming a hydrophobic area along with Phe 22 )

Disclosure: The author is Chief Medical Officer of Vineyard Health, a telehealth obesity medicine practice

Updated July 2026 The Ozempic and GLP-1 gastroparesis lawsuits involve claims that manufacturers of GLP-1 medications such as Ozempic, Wegovy, Mounjaro, Rybelsus, Trulicity, Zepbound, and Saxenda failed to adequately warn patients and doctors about the potential risk of developing gastroparesis (i.e., stomach paralysis or delayed gastric emptying), a serious gastrointestinal injury that can cause persistent nausea, vomiting, abdominal pain, bloating, dehydration, malnutrition, hospitalization, or the need for feeding tubes or other invasive treatment

One thing that often catches people off guard is the digestive side effects: bloating that seems to come out of nowhere, constipation that lingers, sulfur burps, and stomach discomfort that can make meals feel like a chore